Biotech Is Only Expensive When You Follow the Crowd 2 hours ago
Max Nisen is a Bloomberg Gadfly columnist covering biotech, pharma and health care. He previously wrote about management and corporate strategy for Quartz and Business Insider.
from Biotech News
0 Comments